Antibody-drug conjugates (ADCs) are transforming oncology by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. Yet, developing effective ADCs requires overcoming ...

Efficient T-cell engineering is crucial for the success of CAR T-cell therapy research, but it requires multiple labor-intensive steps, including T-cell isolation, activation, and transduction.

Innovative statistical method helps determine ideal threshold times in restricted mean survival time analyses. The restricted mean survival time (RMST) analysis technique was introduced in health care ...

An intelligent inversion framework for soil parameters in deep excavations is established by using BIM technology, finite difference method (FDM), and nondominated sorting genetic algorithm II ...

Chemical derivatization involves the reaction of an analyte with a derivatization agent to modify its structure, improving the peak shape, chromatographic performance, structural analysis, ionization ...

XRD works by directing X-rays onto a crystalline material and analyzing the angles and intensities of the diffracted beams. The atomic planes within the crystal act as a three-dimensional grating, ...

Overlapping and weak fingerprints pose challenges in criminal cases. A new study offers a solution and brings hope for using chemical residues in fingerprints for personal profiling. A groundbreaking ...

ABSTRACT: Changepoint detection faces challenges when outlier data are present. This paper proposes a multivariate changepoint detection method which is based on the robust WPCA projection direction ...

Whether you are a beginner gym-goer or an elite athlete, the goal is always to get stronger — fast. Whenever you talk about getting bigger, stronger, and faster, the conversation ultimately pivots ...

The antibody drug conjugate (ADC) market size was estimated at USD 11.32 billion in 2023 and is projected to grow USD 27.37 billion by 2033, rising at a compound annual growth rate (CAGR) of 9.23% ...

Increased risk of hyperglycemia in patients with advanced urothelial cancer treated with enfortumab vedotin: A systematic review and meta-analysis. Disitamab vedotin combined with fruquintinib in ...